Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT05854303
- Status
- Recruiting
Conditions
- Opioid-Induced Esophageal Dysfunction
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Opioid cessation — BEHAVIORALopioid cessation will occur during pain rehabilitative program over approximately 3 weeks
- No opioid cessation — OTHERSubjects will not stop taking opioids
Study Details
The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED).
Key Dates
- Start date
- Sep 18, 2023
- Status verified
- Oct 2025
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 26 participants (estimated)
Arms
- Arm: Opioid CessationSubjects able to complete opioid cessation.
- Arm: Non-Opioid CessationSubjects unable to complete opioid cessation.
Primary Outcome Measure
Number of subjects to have opioid-induced esophageal dysfunction resolution [ Time Frame: 4 weeks ]
Central Contacts
- Mariah Robran507-266-3595
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic Minnesota | Rochester | Minnesota | 55905 | - |
Find similar trials in Rochester, MN
By research site